Serum antibiotic level is regarded as an important guide, especially in endocarditis or other bacteremic diseases, for predicting antibiotic effects and making subsequent therapeutic programs.
As for the evaluation of serum antibiotic level from the clinical view point or the methodology of serum antibiotic assay itself, however, there have not necessarily been standardized lines yet.
In this paper, the author scrutinized the interrelationship between estimations of serum antibiotic level measured by various methods and clinical effectiveness using four bacteremic patients, the causatives being Staph. epidermidis and Staph. aureus in two sepsis cases (case 1, case 2), respectively, Strept. lactis and Strept. disgalactiae in two endocarditis cases (case 3, case 4), respectively.
The summary is as follows:
In Cup Method using Bacillus subtilis as an indicator, the serum antibiotic concentrations were shown six times or more higher than MIC. In spite of this fact, clinical improvements had hardly been achieved. This method cannot be considered adequate for therapeutic guide.
However, antibiotic containing serum inhibitory power to the isolated agents from the patient (case 3) measured by Cup Method using the isolates as an indicator has been consistent with clinical results.
Antibiotic containing patient sera were tested for growth inhibitory effects to the isolates from the patients by Tube Dilution Method. In case 1, the sera diluted to 1: 2 showed inhibitory effects, but the treatments were proved fruitless clinically. In the other three cases, the treatment succeeded when the sera diluted to 1: 8, 1: 32 and 1: 128, respectively, inhibited the growth of the isolates. In case 3, however, the treatments were unsuccessful while the serum bacteriostatic titer remained 1: 32 under daily 18 million units PC-G regime. To the author's impression, antibiotic therapy based on serum bacteriostatic activity may fail in such a case as the MIC of patients is much lower than its minimal bactericidal concentration.
Bactericidal activities of patients' sera agaist causative organism were assayed by the method described by Schlichter et al. The decline of bactericidal titer of PC-G in the sera to Strept. lactis isolated from SBE case (case 3) was observed when the large dose of organism was inoculated to the medium. Despite daily 18 million units PC-G plus daily 8 gr Lincomycin were administrated in that case, a small number of colonies remained on the medium resisting low or non diluted patient's sera, when undiluted freshly cultured broth was employed. At the same time, the therapy resulted in failure clinically under that dose. The patient was finally cured under the long term treatment of daily 28.8 million units PC-G, however. And, in the case of undiluted freshly cultured broth, 1: 8 dilution of the serum, and in the case of 1: 100 dilution broth, 1: 128 dilution of the serum completely killed the pathogens on the media, respectively. In case 4 of SBE (Strept. dysgalactiae), who was failure clinically under that dose. The patient was finally cured under the long term treatment of under daily 6 gr Cephaloridine regime, 1: 32 dilution of the serum completely killed the causatives even when undiluted fresh culture broth was inoculated. MIC of Cephaloridine was, then, disclosed as 0.1mcg/ml. In this patient, Cephaloridine was conspicuously effective.
It is the author‘s viewpoint that in most cases of bacteremic patients who are poor in the natural healing tendency, most conventionally used bacterial inhibition tests cannot be regarded as adequate guide for antibiotic therapy. From the author’ s experience, undiluted culture broth should be included as the test material among others.
View full abstract